MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

MicroRNA-34 (miR-34) has been reported to be dysregulated in various human cancers and regarded as a tumor suppressive microRNA because of its synergistic effect with the well-known tumor suppressor p53. Along with the application of MRX34, the first tumor-targeted microRNA drug which based on miR-34a mimics, on phase I clinical trial (NCT01829971), the significance of miR-34 is increasingly recognized. miR-34 plays a crucial role on repressing tumor progression by involving in epithelial-mesenchymal transition (EMT) via EMT- transcription factors, p53 and some important signal pathways. Not only that, numerous preclinical researches revealed the giant potential of miR-34a on cancer therapy through diversiform nano-scaled delivery systems. Here, we provide an overview about the function of miR-34 in various cancers and the mechanism of miR-34 in tumor-associated EMT. Furthermore, its potential role as a microRNA therapeutic candidate is also discussed. Notwithstanding some obstacles existed, the extensive application prospect of miR-34 on oncotherapy cannot be neglected.

• Publication year

  2019

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  2019-02-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/s13046-019-1059-5PMID 30717802PMCID 6360685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer.

  2019influential reference
• Treating cancer with microRNA replacement therapy: A literature review

  2018cited by this paper
• Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer

  2018influential reference
• One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?

  2018cited by this paper
• MicroRNA-34 family in breast cancer: from research to therapeutic potential

  2018cited by this paper
• MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis

  2018cited by this paper
• miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding

  2018cited by this paper
• Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

  2018cited by this paper
• RETRACTED: miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA

  2018cited by this paper
• MicroRNA‐421 suppresses the apoptosis and autophagy of hippocampal neurons in epilepsy mice model by inhibition of the TLR/MYD88 pathway

  2018cited by this paper
• Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines.

  2018cited by this paper
• Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer

  2018cited by this paper
• MiR-34a Enhances Chondrocyte Apoptosis, Senescence and Facilitates Development of Osteoarthritis by Targeting DLL1 and Regulating PI3K/AKT Pathway

  2018cited by this paper
• Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.

  2018cited by this paper
• A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update

  2018cited by this paper
• MicroRNA‐34a‐5p inhibits liver fibrosis by regulating TGF‐β1/Smad3 pathway in hepatic stellate cells

  2018cited by this paper
• The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling.

  2018cited by this paper
• miR-34a directly targets tRNAiMet precursors and affects cellular proliferation, cell cycle, and apoptosis

  2018cited by this paper
• MicroRNA‐198 inhibition of HGF/c‐MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non–small‐cell lung cancer

  2018cited by this paper
• MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells

  2018cited by this paper
• Regulation of miR-34b/c-targeted gene expression program by SUMOylation

  2018cited by this paper
• miR-34 inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression

  2018influential reference
• Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.

  2018cited by this paper
• miRNAs in immune responses to Mycobacterium tuberculosis infection.

  2018cited by this paper
• miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein

  2018influential reference
• MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines

  2018cited by this paper
• Advancements in the design and scalable production of viral gene transfer vectors

  2018cited by this paper
• MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

  2017cited by this paper
• miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness

  2017cited by this paper
• Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly

  2017cited by this paper
• Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway

  2017influential reference
• MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling

  2017cited by this paper
• miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1

  2017cited by this paper
• Therapeutic targeting of non-coding RNAs in cancer.

  2017cited by this paper
• MicroRNAs and clinical implications in hepatocellular carcinoma

  2017influential reference
• Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment

  2017cited by this paper
• MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells

  2017cited by this paper
• Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b

  2017cited by this paper
• Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer

  2017cited by this paper
• S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis

  2017cited by this paper
• The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma.

  2017cited by this paper
• Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

  2017cited by this paper
• The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes

  2017cited by this paper
• Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit

  2017cited by this paper
• Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

  2017cited by this paper
• miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis.

  2017cited by this paper
• Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.

  2017cited by this paper
• Circulating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer.

  2017cited by this paper
• Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis

  2017cited by this paper
• MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.

  2017cited by this paper
• Altered expression of apoptosis-regulating miRNAs in salivary gland tumors suggests their involvement in salivary gland tumorigenesis

  2017cited by this paper
• Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1

  2017influential reference
• Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

  2016cited by this paper
• The orphan nuclear receptor NR4A2 is part of a p53–microRNA-34 network

  2016cited by this paper
• miR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage

  2016cited by this paper
• MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

  2016cited by this paper
• Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.

  2016cited by this paper
• Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.

  2016cited by this paper
• A redox-sensitive, oligopeptide-guided, self-assembling, and efficiency-enhanced (ROSE) system for functional delivery of microRNA therapeutics for treatment of hepatocellular carcinoma.

  2016cited by this paper
• Expression of stem cell-regulating miRNAs in oral cavity and oropharynx squamous cell carcinoma.

  2016cited by this paper
• The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms

  2016cited by this paper
• Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation

  2015cited by this paper
• miR-34 and p53: New Insights into a Complex Functional Relationship

  2015cited by this paper
• The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels

  2015cited by this paper
• Lipid-Based Nanocarriers for RNA Delivery

  2015cited by this paper
• miR-34a Inhibits Proliferation and Invasion of Bladder Cancer Cells by Targeting Orphan Nuclear Receptor HNF4G

  2015cited by this paper
• PDL1 Regulation by p53 via miR-34

  2015cited by this paper
• Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features

  2015cited by this paper
• microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway

  2015cited by this paper
• Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

  2015cited by this paper
• Principles of nanoparticle design for overcoming biological barriers to drug delivery

  2015cited by this paper
• LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a

  2015cited by this paper
• Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer

  2015cited by this paper
• A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a Mimic.

  2015cited by this paper
• Mir-34: A New Weapon Against Cancer?

  2014cited by this paper
• Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.

  2014cited by this paper
• In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma

  2014cited by this paper
• Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis.

  2014cited by this paper
• A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer

  2014cited by this paper
• Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma

  2014cited by this paper
• Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.

  2014cited by this paper
• The p53/miR-34 axis in development and disease.

  2014cited by this paper
• miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells

  2014cited by this paper
• Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF

  2014cited by this paper
• Small RNA combination therapy for lung cancer

  2014cited by this paper
• TGF-β–induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops

  2014cited by this paper
• IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

  2014cited by this paper
• Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells

  2014cited by this paper
• Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer

  2014cited by this paper
• Evaluation of MicroRNA expression pattern of gastric adenocarcinoma associated with socioeconomic, environmental and lifestyle factors in northwestern Hungary.

  2013cited by this paper
• Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model

  2013cited by this paper
• MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation

  2013cited by this paper
• A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

  2013cited by this paper
• Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells

  2013cited by this paper
• MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

  2013cited by this paper
• MicroRNAs in the p53 network: micromanagement of tumour suppression

  2012cited by this paper
• MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin

  2012cited by this paper
• Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

  2012cited by this paper

• From miRNA to Neutrophil Extracellular Traps: Recent Advances in the Regulatory Mechanisms of Sepsis

  2026cites this paper
• Hsa-microRNA-34a-5p inhibits virus-negative Merkel cell carcinoma cell proliferation and migration by regulating cell cycle- and EMT-related pathways and suppresses tumor spheroid formation

  2026cites this paper
• Non-Coding RNAs in breast cancer bone metastasis: Regulators and novel therapeutic targets.

  2026cites this paper
• The miRNA-4330/ABCG2 axis overcomes drug resistance and cancer progression in both ER-positive and ER-negative resistant breast cancer cells.

  2026cites this paper
• Recent advances in bioanalytical technologies for oligonucleotide therapeutics: Technical progress and methodological challenges

  2026cites this paper
• M1 Macrophage-Derived Small Extracellular Vesicles as Synergistic Nanotherapeutics: Harnessing Intrinsic Anticancer Activity and Drug Delivery Capacity.

  2026cites this paper
• Involvement of Non-Coding RNAs in the Glucose Metabolic Reprogramming of Oral Squamous Cell Carcinoma: From Mechanisms to Therapeutics

  2026cites this paper
• Disruption of the ∆40p53/miR-4671-5p/SGSH axis results in intra-S-phase arrest and poor cancer prognosis.

  2026cites this paper
• hsa_circ_0006156 Suppresses Malignant Progression by Inducing Ferroptosis in Gastric Cancer Via miR-942-5p/NCOA4 Axis.

  2026cites this paper
• MicroRNA Regulation in Cancer: Insights into Diagnosis, Prognosis, and Treatment

  2026cites this paper
• hsa_circ_0001776 regulates the progression of acute myeloid leukemia through the miR-1269b/PTEN axis

  2025cites this paper
• Cancer cell-derived exosomal miR-34a inhibits the malignant progression of pancreatic adenocarcinoma cells by restraining the M2 polarization of macrophages

  2025cites this paper
• Dysregulation of microRNA (miRNA) Due to Phthalate/Phthalate Metabolite Exposure and Associated Health Effects: A Narrative Review

  2025cites this paper
• Spatiotemporally controlled delivery of biomacromolecules via injectable hydrogels for precision modulation of the tumor immune microenvironment

  2025cites this paper
• Effect of conditioned medium from miRNA-34a transfected gastric cancer-associated fibroblast on peripheral blood mononuclear cells

  2025cites this paper
• Clinical implications of epithelial-to-mesenchymal transition in cancers which potentially spread to peritoneum

  2025cites this paper
• Post-transcriptional regulation by HuR in colorectal cancer: impacts on tumor progression and therapeutic strategies

  2025cites this paper
• Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion

  2025cites this paper
• Research on Buyang Yiwei Decoction in the Treatment of Gastric Cancer Based on PI3K/AKT Signaling Pathway: A Review

  2025cites this paper
• Peptide-Mediated Modulation of miRNAs: A Novel Therapeutic Strategy for Cancer

  2025cites this paper
• MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential

  2025cites this paper
• microRNA-34: A multifunctional miRNA family.

  2025cites this paper
• MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications

  2025cites this paper
• Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines

  2025cites this paper
• Utilizing miR-34a-Loaded HER2-Targeting Exosomes to Improve Breast Cancer Treatment: Insights From an Animal Model

  2025cites this paper
• MiR-34c Is Predictive of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

  2025cites this paper
• A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma

  2025cites this paper
• Evaluation of Circulating miR-155, miR-221, miR-34a, and miR-143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer.

  2025cites this paper
• Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma

  2025cites this paper
• RNA-based drugs: current, imminent and possible therapeutic applications.

  2025cites this paper
• Platycodin D inhibits non-small cell lung cancer bone metastasis by inducing ferroptosis through miR-877-3P/PNMA5 regulatory axis.

  2025cites this paper
• Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial–mesenchymal transition in hepatocellular carcinoma

  2025cites this paper
• Regulatory Mechanisms of miRNA Turnover: Insights into ZSWIM8-Mediated Target-Directed MicroRNA Degradation

  2025cites this paper
• Sericin induces apoptosis in the ovarian cancer cell line (OVCAR-3) through the miR-34a-related pathway

  2025cites this paper
• Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications

  2025cites this paper
• miRNA-mediated resistance mechanisms in prostate cancer: implications for targeted therapy and metastatic progression

  2025cites this paper
• Multigene RNAi Technology to Treat Cancer: Harnessing Synergistic Gene Regulation to Combat Evolving Cancer.

  2025cites this paper
• HER3 promotes triple-negative breast cancer progression by upregulating PHF8 via miR-34b-5p-dependent mechanism

  2025cites this paper
• MicroRNA Gets a Mighty Award

  2025cites this paper
• MicroRNA profiling identifies novel regulators of stem cell function in the adult Drosophila intestine

  2025cites this paper
• Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases.

  2025cites this paper
• HNF4α as a Master Regulator of Epigenetic Dynamics in Epithelial Cells

  2025cites this paper
• The role of abnormal epigenetic regulation of small GTPases in glioma (Review)

  2025cites this paper
• MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines

  2025cites this paper
• Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases

  2025cites this paper
• The role of miR-16 and miR-34a family in the regulation of cancers: A review

  2025cites this paper
• Quercetin-Mediated Modulation of Tumor Suppressor miR-15a, miR-34a, and p53 Signaling in MCF-7 Breast Cancer Cells

  2025cites this paper
• The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors

  2025cites this paper
• MicroRNA-34a Mediates the Aldosterone-Induced Acceleration of Endothelial Senescence

  2025cites this paper
• Inter-Tissue Communication Mechanisms via Exosomes and Their Implications in Metabolic Diseases: Opportunities for Pharmacological Regulation

  2025cites this paper
• Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases

  2025cites this paper
• miR-378d suppresses gastric cancer metastasis by targeting METTL4 to inhibit epithelial-mesenchymal transition

  2025cites this paper
• Non-coding RNAs, a double-edged sword in breast cancer prognosis

  2025cites this paper
• Current updates regarding biogenesis, functions and dysregulation of microRNAs in cancer: Innovative approaches for detection using CRISPR/Cas13-based platforms (Review)

  2025cites this paper
• Investigating the anticancer and synergistic effects of the combination of green synthesized silver nanoparticles and papaverine on breast cancer cell lines: focusing on the apoptosis pathway and microRNA regulation

  2025cites this paper
• Suppression of Cellular Proliferation in PC3 Prostate Cancer Cells by Green Tea Extract Through Induction of miR‐34a Expression

  2025cites this paper
• Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosis

  2025cites this paper
• Exploring miRNA Research in Colorectal Cancer: Insights from a Bibliometric Analysis

  2025cites this paper
• Wearable nanopatch platforms for real-time miRNA sensing and editing: a vision for next-generation cancer management

  2025cites this paper
• Overview of the Different Classes of Small RNAs During B-Cell Development.

  2025cites this paper
• Dual Regulation and Clinical Application of miR-34 in Virus-Related Tumors Through Anti-Viral Immunity and Tumor Suppression

  2025cites this paper
• Integrated therapies for targeting the microenvironment of hepatocellular carcinoma.

  2025cites this paper
• miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis

  2025cites this paper
• MicroRNA-34a-5p induces cell cycle arrest and leads to spermatogenesis failure by targeting CDC25A

  2025cites this paper
• Inhalable Perfluorocarbon RNA Nanocapsules Bypass Immune Clearance While Targeting Lung Epithelial and Lung Tumor Cells

  2025influential citation
• The Converging Roles of microRNAs and Lipid Metabolism in Atherosclerotic Cardiovascular Disease and Cancer.

  2025cites this paper
• Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment

  2025cites this paper
• m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p

  2025cites this paper
• Molecular insight into the therapeutic potential of miR-34a in retinoblastoma

  2025cites this paper
• Engineered gold nanoparticle-based miRNA precision regulation for tumor diagnosis and synergistic therapy

  2025cites this paper
• Cancer and Cardiovascular Disease

  2025cites this paper
• MicroRNAs at the crossroad of cancer therapeutics: insights from WNT signaling & flavonoids

  2025cites this paper
• Exploring the Impact of miR‐34b‐5p on BRD4 Gene Expression in Triple‐Negative Breast Cancer Cells

  2025cites this paper
• Exploring the therapeutic potential of microRNAs: targeted gene regulation strategies for enhanced cancer therapy

  2025cites this paper
• Advances in targeting glycogen synthase kinase 3β for diabetes therapy.

  2025cites this paper
• Epithelial-mesenchymal-associated non-coding RNAs as Breast cancer metastasis biomarkers

  2025cites this paper
• JunD-miR494-CUL3 axis promotes radioresistance and metastasis by facilitating EMT and restraining PD-L1 degradation in esophageal squamous cell carcinoma.

  2024cites this paper
• Expression of mir34a in Children with Progressive Familial Intrahepatic Cholestasis: A Cross-Sectional Study Based on Shiraz Pediatric Liver Cirrhosis Cohort Study

  2024cites this paper
• Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

  2024cites this paper
• Impact of Long-Lasting Environmental Factors on Regulation Mediated by the miR-34 Family

  2024cites this paper
• Selective inhibition of partial EMT-induced tumour cell growth by cerium valence states of extracellular ceria nanoparticles for anticancer treatment.

  2024cites this paper
• CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation

  2024cites this paper
• The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy

  2024cites this paper
• Analyzing the expression pattern of the noncoding RNAs (HOTAIR, PVT‐1, XIST, H19, and miRNA‐34a) in PBMC samples of patients with COVID‐19, according to the disease severity in Iran during 2022–2023: A cross‐sectional study

  2024cites this paper
• MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer

  2024cites this paper
• MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer

  2024cites this paper
• PLASMA: Partial LeAst Squares for Multiomics Analysis

  2024cites this paper
• Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises

  2024cites this paper
• Pan-cancer molecular signatures connecting aspartate transaminase (AST) to cancer prognosis, metabolic and immune signatures

  2024cites this paper
• MiR-103a-3p Promotes Tumorigenesis of Breast Cancer by Targeting ETNK1

  2024cites this paper
• Clinical Implementation of MicroRNAs in Cancer Immunology

  2024cites this paper
• A comprehensive integrated gene network construction to explore the essential role of Notch 1 in lung adenocarcinoma (LUAD)

  2024cites this paper
• Design, Synthesis, and Antitumor Activity Evaluation of 2-Phenylthiazole-5-Carboxylic Acid Derivatives Targeting Transactivation Response RNA-Binding Protein 2.

  2024cites this paper
• Expression characteristics of miR-222b-5p/MAPK10 in major immune organs of SPF chickens infected with avian reticuloendotheliosis virus strain SNV (REV-SNV).

  2024cites this paper
• Extracellular Vesicles in Viral Liver Diseases

  2024cites this paper
• High mobility group protein N2 inhibits the progression of hepatocellular carcinoma and the related molecular mechanisms

  2024cites this paper
• Sex differences in the tumor promoting effects of tobacco smoke in a cRaf transgenic lung cancer disease model

  2024cites this paper
• miRNA interplay: Mechanisms and therapeutic interventions in cancer

  2024cites this paper
• Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155

  2024cites this paper
• Lower expressions of MIR34A and MIR31 in colo-rectal cancer are associated with an enriched immune microenvironment.

  2024cites this paper